Epilepsy Surgery

Epilepsy surgery is a group of operations that treat epilepsy by addressing the small area of the brain where the seizures start, known as the seizure focus. The most common form is resective surgery, in which that focus is carefully removed; temporal lobe surgery, for seizures arising deep in the temporal lobe, is the best-established example and offers high rates of becoming seizure free in suitable patients. When the focus cannot be safely removed, disconnective surgery interrupts the pathways that let seizures spread, reducing their severity and frequency. For people who are not candidates for either, neuromodulation devices, such as a stimulator placed on a nerve in the neck, deliver regular pulses that lower seizure burden over time. Surgery does not suit everyone, but for carefully chosen patients with drug-resistant epilepsy it can change the course of the condition, and the goal is always to gain seizure control while protecting the brain's important functions.

Surgery is considered for drug-resistant epilepsy, meaning seizures that continue despite two or more suitable, properly dosed medications, a situation that affects roughly one in three people with epilepsy. Continuing uncontrolled seizures carry real risks to safety, independence and quality of life, so once medication has failed, an early surgical evaluation is sensible rather than waiting indefinitely. The ideal candidate has a single, well-defined seizure focus in an area that can be removed without causing unacceptable loss of function. Surgery is also strongly considered when an underlying lesion, such as scarring, a developmental abnormality or a small tumour, is driving the seizures. Children with drug-resistant epilepsy are evaluated in the same careful way, and the developing brain often shows a remarkable ability to recover after successful surgery. The decision is always made by a team, only when the likely benefit clearly outweighs the risk.

The evaluation comes first and is as important as the operation. It typically includes extended video monitoring of brain activity to capture seizures, high-resolution MRI to find any structural cause, and tests of memory, language and other functions to map what must be protected; further functional and metabolic imaging may be added. When non-invasive tests cannot pinpoint the focus precisely, a staged procedure places fine electrodes inside the skull to record directly from the brain and map the exact area before any tissue is removed. The operation itself is usually carried out under general anaesthesia through a small opening in the skull, using a microscope, real-time navigation that overlays the imaging onto the surgical field, and continuous monitoring of nerve pathways so the team is alerted to any change. When the focus lies close to speech or movement areas, awake surgery lets the patient respond to testing while the surgeon works, maximising safety. Where the cause is a small tumour or abnormal tissue, fluorescence techniques can help make it visible. The operation usually takes about 3 to 6 hours.

A suitable candidate is someone with drug-resistant epilepsy whose seizures arise from an area that can be safely treated, confirmed through the detailed evaluation above. Not everyone is a candidate: if seizures come from several areas, or from a region essential for speech, movement or memory that cannot be spared, removal may not be advised, and neuromodulation may be offered instead. Preparation centres on completing the monitoring, imaging and neuropsychological testing that locate the focus and define the risks, followed by routine blood tests, heart checks and a medication review; epilepsy medicines are continued and adjusted around surgery on specialist advice. A clear discussion of the realistic chance of seizure freedom and the possible effects on function is an essential part of consent. For international patients, much of the early review can begin remotely: existing scans, monitoring results and seizure histories are assessed before travel, so the plan and any remaining tests can be arranged efficiently on arrival.

After surgery most patients stay in hospital for about 3 to 6 days, during which the team watches for early seizures, monitors recovery and checks the wound before discharge. Headache and tiredness are common in the first weeks and settle steadily, while full recovery at home generally takes about 4 to 8 weeks with a gradual return to normal activity. Importantly, seizure control is judged over months rather than days, and epilepsy medication is usually continued for a period after surgery and then reduced slowly under specialist guidance based on how seizures respond. When planning treatment abroad, it is sensible to allow roughly 2 to 3 weeks in the destination city for any final evaluation, the surgery, wound healing and a follow-up review before flying. Air travel is generally safe once the team confirms the wound is healing well. Afterwards, follow-up continues remotely with shared records, scans and video, medication changes are coordinated with a specialist near home, and international patient teams provide interpreters and coordinators so language is never a barrier.

In experienced hands and a properly equipped hospital, epilepsy surgery is a well-established treatment, and the thorough evaluation beforehand is designed specifically to keep it safe. As with any brain operation it carries some risk, including bleeding, infection, swelling and, depending on the area treated, temporary or, less often, lasting changes in memory, language, vision or movement; these possibilities are mapped out in advance so the plan protects what matters most. The benefit can be considerable: in well-selected patients, particularly those with a clear single focus such as temporal lobe epilepsy, a large proportion become free of disabling seizures, and many of the rest have far fewer. Becoming seizure free can mean returning to driving, work and independent life. Neuromodulation, when surgery to remove the focus is not possible, steadily lowers seizure burden rather than aiming for an immediate cure. With careful selection, precise surgery and close follow-up, most patients gain meaningful, lasting seizure control.